T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.13% |
| 2 | Consumer Discretionary | 15.13% |
| 3 | Financials | 13.68% |
| 4 | Technology | 12.92% |
| 5 | Industrials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCG
1076
DELISTED
Scana
SCG
| $19.9M | ﹤0.01% |
284,068
+13,800
| +5% | +$892K |
|
1077
Williams Companies
WMB
$90.1B
| $19.9M | ﹤0.01% |
1,236,608
-3,000
| -0.2% | -$51.6K |
|
1078
MaxLinear
MXL
$6.95B
| $19.8M | ﹤0.01% |
1,072,935
-153,175
| -12% | -$2.43M |
|
1079
Eastman Chemical
EMN
$8.29B
| $19.8M | ﹤0.01% |
273,737
+17,091
| +7% | +$1.12M |
|
|
KYNB
1080
Kyntra Bio
KYNB
$28.7M
| $19.7M | ﹤0.01% |
37,053
-110
| -0.3% | -$54.8K |
|
1081
Dover
DOV
$28B
| $19.6M | ﹤0.01% |
377,418
+40,801
| +12% | +$1.98M |
|
|
LDL
1082
DELISTED
Lydall, Inc.
LDL
| $19.5M | ﹤0.01% |
599,360
-16,730
| -3% | -$491K |
|
|
SFE
1083
DELISTED
Safeguard Scientifics, Inc.
SFE
| $19.5M | ﹤0.01% |
1,468,690
-35,353
| -2% | -$445K |
|
|
OSG
1084
DELISTED
Overseas Shipholding Group Inc.
OSG
| $19.4M | ﹤0.01% |
+1,722,343
| New | +$23.8M |
|
1085
Sportsman's Warehouse
SPWH
$46M
| $19.4M | ﹤0.01% |
1,538,560
-18,000
| -1% | -$229K |
|
1086
Waters Corp
WAT
$40.6B
| $19.3M | ﹤0.01% |
146,656
+600
| +0.4% | +$74.8K |
|
1087
Churchill Downs
CHDN
$6.2B
| $19.2M | ﹤0.01% |
780,060
+428,280
| +122% | +$9.79M |
|
1088
U-Haul Holding Co
UHAL
$14.5B
| $19.1M | ﹤0.01% |
535,250
-8,700
| -2% | -$303K |
|
1089
United Therapeutics
UTHR
$21.9B
| $19.1M | ﹤0.01% |
171,413
+580
| +0.3% | +$73.4K |
|
1090
Xerox
XRX
$412M
| $19.1M | ﹤0.01% |
649,082
-3,363
| -0.5% | -$86.7K |
|
1091
Ares Capital
ARCC
$14.5B
| $19.1M | ﹤0.01% |
1,285,900
-105,650
| -8% | -$1.46M |
|
1092
Coca-Cola Consolidated
COKE
$12.6B
| $19.1M | ﹤0.01% |
1,194,040
-78,200
| -6% | -$1.33M |
|
1093
Live Oak Bancshares
LOB
$1.98B
| $19M | ﹤0.01% |
1,269,694
+16,478
| +1% | +$223K |
|
1094
Stewart Information Services
STC
$2B
| $19M | ﹤0.01% |
524,464
+77,994
| +17% | +$2.64M |
|
1095
Utah Medical Products
UTMD
$230M
| $19M | ﹤0.01% |
304,200
+900
| +0.3% | +$53.1K |
|
1096
Steel Dynamics
STLD
$37.7B
| $19M | ﹤0.01% |
843,225
-75,231
| -8% | -$1.42M |
|
1097
Outfront Media
OUT
$5.29B
| $19M | ﹤0.01% |
913,844
-11,075
| -1% | -$225K |
|
1098
Duluth Holdings
DLTH
$151M
| $18.9M | ﹤0.01% |
971,820
+95,961
| +11% | +$1.59M |
|
1099
Capri Holdings
CPRI
$1.77B
| $18.9M | ﹤0.01% |
332,245
-5,980
| -2% | -$295K |
|
1100
ICU Medical
ICUI
$4.58B
| $18.9M | ﹤0.01% |
181,550
+42,410
| +30% | +$4.05M |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.